New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Dynavax Technologies Corporation
DVAX
Shape
US Flag

NASDAQ

2B

Drug Manufacturers - Specialty & Generic

Next Earning date - 14 May 2025

2B

Drug Manufacturers - Specialty & Generic

Next Earning date - 14 May 2025

13.09USD

Shape0.16 ( 1.24%)
Market Closed (as of Feb 19, 21:00 EDT)
favorite-chart

Relative Strenght

83
favorite-chart

Volume Buzz

49%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

11%

Quote Panel

Shape
Updated March 23, 2025
1W 1.39 % 1M 2.98 % 3M 7.63 % 1Y 10.56 %

Key Metrics

Shape
  • Market Cap

    1.71B


  • Shares Outstanding

    124.07M


  • Share in Float

    118.28M


  • Dividende

    0


  • Earning Date

    14 May 2025


  • Price Target

    13.82


  • Average Volume

    2.16M


  • Beta

    1.231


  • Range

    9.74-14.63


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.dynavax.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

DVAX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$327M

Shape353%

2025-Revenue

$0.34

Shape513%

2025-EPS

$10M

Shape-180%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

JMP Securities

initialise

Previous: Not converted

2022-09-27

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.19
vs 0.22

Q2.23

arrow
arrow

-97%

0.03
vs 0.87

Q3.23

arrow
arrow

-77%

0.1
vs 0.43

Q4.23

arrow
arrow

-100%

0
vs 0.45

Q1.24

arrow
arrow

N/A

-0.07
vs -0.19

Q2.24

arrow
arrow

+167%

0.08
vs 0.03

Q3.24

arrow
arrow

+20%

0.12
vs 0.1

Q4.24

arrow
arrow

+2949%

0.05
vs 0

Q1.25

arrow
arrow

+157%

0.04
vs -0.07

Q2.25

arrow
arrow

+28%

0.1
vs 0.08

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-59%

46.9M  vs 114M

Q2.23

arrow
arrow

-77%

60.2M  vs 256.5M

Q3.23

arrow
arrow

-59%

69.5M  vs 167.7M

Q4.23

arrow
arrow

-70%

55.6M  vs 184.5M

Q1.24

arrow
arrow

+8%

50.8M  vs 46.9M

Q2.24

arrow
arrow

+22%

73.8M  vs 60.2M

Q3.24

arrow
arrow

+16%

80.6M  vs 69.5M

Q4.24

arrow
arrow

+30%

72M  vs 55.6M

Q1.25

arrow
arrow

+40%

71.2M  vs 50.8M

Q2.25

arrow
arrow

+14%

84.1M  vs 73.8M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-4%

-0.04
vs 0.12

Q2.23

arrow
arrow

+1%

0.01
vs -0.04

Q3.23

arrow
arrow

+2%

0.02
vs 0.01

Q4.23

arrow
arrow

+0%

0
vs 0.02

Q1.24

arrow
arrow

-1%

-0.01
vs 0

Q2.24

arrow
arrow

+2%

0.02
vs -0.01

Q3.24

arrow
arrow

+3%

0.03
vs 0.02

Q4.24

arrow
arrow

+1%

0.01
vs 0.03

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

216

216
vs 241

-10%

Q2.23

arrow
arrow

218

218
vs 216

1%

Q3.23

arrow
arrow

231

231
vs 218

6%

Q4.23

arrow
arrow

247

247
vs 231

7%

Q1.24

arrow
arrow

256

256
vs 247

4%

Q2.24

arrow
arrow

244

244
vs 256

-5%

Q3.24

arrow
arrow

258

258
vs 244

6%

Q4.24

arrow
arrow

267

267
vs 258

3%

Earnings Growth

Latest News